이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Sky Blue 11 미래 성장

Future 기준 확인 0/6

현재 Sky Blue 11 의 성장과 수익을 예측할 만큼 분석가의 범위가 충분하지 않습니다.

주요 정보

n/a

수익 성장률

n/a

EPS 성장률

Semiconductor 수익 성장	29.0%
매출 성장률	n/a
향후 자기자본 수익률	n/a
애널리스트 커버리지	None
마지막 업데이트	n/a

최근 미래 성장 업데이트

Recent updates

Sky Blue 11 Company Limited's (HKG:1010) 32% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Aug 07

Balk 1798 Group Limited (HKG:1010) Soars 29% But It's A Story Of Risk Vs Reward

Mar 14

It's Down 26% But Balk 1798 Group Limited (HKG:1010) Could Be Riskier Than It Looks

Jan 23

Not Many Are Piling Into Balk 1798 Group Limited (HKG:1010) Stock Yet As It Plummets 26%

Jan 22

If You Had Bought PacRay International Holdings' (HKG:1010) Shares Three Years Ago You Would Be Down 34%

Jan 13

이 섹션에서는 일반적으로 투자자가 회사의 수익 창출 능력을 이해하는 데 도움이 되도록 전문 애널리스트의 컨센서스 추정치를 기반으로 수익 및 수익 성장 전망치를 제시합니다. 하지만 Sky Blue 11 은 충분한 과거 데이터를 제공하지 않았고 애널리스트 예측도 없기 때문에 과거 데이터를 추정하거나 애널리스트 예측을 사용하여 미래 수익을 안정적으로 계산할 수 없습니다.

SimplyWall St에서 다루는 기업의 97%가 과거 재무 데이터를 가지고 있기 때문에 이는 매우 드문 상황입니다.

수익 및 매출 성장 예측

SEHK:1010 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (HKD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
6/30/2024	28	-70	-72	-72	N/A
3/31/2024	71	-58	-53	-53	N/A
12/31/2023	114	-46	-33	-33	N/A
9/30/2023	177	-17	-6	-6	N/A
6/30/2023	239	12	21	21	N/A
3/31/2023	210	5	20	20	N/A
12/31/2022	181	-2	20	20	N/A
9/30/2022	138	-30	-56	-55	N/A
6/30/2022	95	-57	-132	-130	N/A
3/31/2022	100	-55	-133	-131	N/A
12/31/2021	106	-53	-134	-132	N/A
9/30/2021	109	-34	-59	-57	N/A
6/30/2021	112	-15	17	17	N/A
3/31/2021	102	-10	20	20	N/A
12/31/2020	93	-5	23	23	N/A
9/30/2020	91	-10	19	17	N/A
6/30/2020	89	-14	14	11	N/A
3/31/2020	82	-17	3	2	N/A
12/31/2019	74	-21	-9	-8	N/A
9/30/2019	60	-32	-20	-18	N/A
6/30/2019	45	-43	-31	-29	N/A
3/31/2019	53	-42	-33	-30	N/A
12/31/2018	61	-40	-35	-32	N/A
9/30/2018	61	-24	-42	-38	N/A
6/30/2018	61	-7	-49	-44	N/A
3/31/2018	49	-5	N/A	-31	N/A
12/31/2017	37	-3	N/A	-19	N/A
9/30/2017	29	0	N/A	-8	N/A
6/30/2017	21	3	N/A	3	N/A
3/31/2017	19	-1	N/A	-3	N/A
12/31/2016	17	-5	N/A	-9	N/A
9/30/2016	16	-14	N/A	-9	N/A
6/30/2016	14	-23	N/A	-9	N/A
3/31/2016	14	-24	N/A	-12	N/A
12/31/2015	14	-25	N/A	-14	N/A
9/30/2015	14	-22	N/A	-13	N/A
6/30/2015	14	-19	N/A	-12	N/A
3/31/2015	14	-1	N/A	-9	N/A
12/31/2014	14	17	N/A	-6	N/A
9/30/2014	13	20	N/A	-8	N/A
6/30/2014	13	23	N/A	-9	N/A
3/31/2014	13	34	N/A	-10	N/A
12/31/2013	12	46	N/A	-10	N/A

애널리스트 미래 성장 예측

수입 대 저축률: 1010 의 예상 수익 증가율이 절약률( 2.3% )보다 높은지 판단하기에는 데이터가 부족합니다.

수익 vs 시장: 1010 의 수익이 Hong Kong 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: 1010 의 수익이 향후 3년 동안 상당히 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

수익 대 시장: 1010 의 수익이 Hong Kong 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: 1010 의 수익이 연간 20% 보다 빠르게 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: 1010 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

Sky Blue 11 미래 성장

Future 기준 확인 0/6

주요 정보

최근 미래 성장 업데이트

PacRay International Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2021

PacRay International Holdings Limited Provides Earnings Guidance for the Year Ended December 31, 2020

Recent updates

Sky Blue 11 Company Limited Appoints Mak Tin Sang as Independent Non-Executive Director, Member of Audit Committee, Nomination Committee and Remuneration Committee

New major risk - Financial position

Sky Blue 11 Company Limited to Report First Half, 2024 Results on Aug 30, 2024

Sky Blue 11 Company Limited Announces Termination of Lam Fuk Tak as Chief Executive Officer

Sky Blue 11 Company Limited's (HKG:1010) 32% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Sky Blue 11 Company Limited Announces Board Retirements

Sky Blue 11 Company Limited Announces Executive Changes

Sky Blue 11 Company Limited, Annual General Meeting, Jun 06, 2024

Sky Blue 11 Company Limited has filed a Follow-on Equity Offering in the amount of HKD 146.617076 million.

New major risk - Negative shareholders equity

Full year 2023 earnings released: HK$0.13 loss per share (vs HK$0.006 loss in FY 2022)

Now 22% overvalued

Balk 1798 Group Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Balk 1798 Group Limited (HKG:1010) Soars 29% But It's A Story Of Risk Vs Reward

Now 22% overvalued

Now 44% overvalued

It's Down 26% But Balk 1798 Group Limited (HKG:1010) Could Be Riskier Than It Looks

Not Many Are Piling Into Balk 1798 Group Limited (HKG:1010) Stock Yet As It Plummets 26%

New minor risk - Shareholder dilution

New minor risk - Market cap size

Investor sentiment deteriorates as stock falls 39%

Does Balk 1798 Group (HKG:1010) Have A Healthy Balance Sheet?

New minor risk - Share price stability

Investor sentiment improves as stock rises 31%

First half 2023 earnings released: HK$0.002 loss per share (vs HK$0.042 loss in 1H 2022)

Balk 1798 Group Limited to Report First Half, 2023 Results on Aug 30, 2023

Shareholders Should Be Pleased With Balk 1798 Group Limited's (HKG:1010) Price

Balk 1798 Group Limited, Annual General Meeting, Jun 06, 2023

High number of new and inexperienced directors

Balk 1798 Group (HKG:1010) Takes On Some Risk With Its Use Of Debt

High number of new and inexperienced directors

First half 2022 earnings released: HK$0.042 loss per share (vs HK$0.029 loss in 1H 2021)

PacRay International Holdings Limited Announces Executive Changes

First half 2022 earnings released: HK$0.042 loss per share (vs HK$0.029 loss in 1H 2021)

PacRay International Holdings Limited to Report First Half, 2022 Results on Aug 30, 2022

PacRay International Holdings Limited, Annual General Meeting, Jun 06, 2022

High number of new and inexperienced directors

Full year 2021 earnings released: HK$0.14 loss per share (vs HK$0.016 loss in FY 2020)

PacRay International Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2021

PacRay International Holdings Limited Appoints Wang Yi as the Executive Director, with Effect from March 8, 2022

PacRay International Holdings Limited Announces Resignation of Duan Hongtao as Executive Director and Chairman of the Board

Non-Executive Director & Company Secretary Danqing Zhou has left the company

Executive Director Yinsheng Xu has left the company

First half 2021 earnings released: HK$0.029 loss per share (vs HK$0.004 loss in 1H 2020)

Executive Director Lin Yang has left the company

Executive Director has left the company

Independent Non-Executive Director has left the company

Executive Director has left the company

Full year 2020 earnings released: HK$0.016 loss per share (vs HK$0.063 loss in FY 2019)

PacRay International Holdings Limited Provides Earnings Guidance for the Year Ended December 31, 2020

PacRay International Holdings Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

New 90-day high: HK$1.96

Zhongying Int’l Holding Group Limited completed the acquisition of 45.1% stake in PacRay International Holdings Limited (SEHK:1010) from Vision2000 Venture Ltd. and other shareholders for approximately HKD 230 million.

If You Had Bought PacRay International Holdings' (HKG:1010) Shares Three Years Ago You Would Be Down 34%

Zhongying Int’l Holding Group Limited made an offer to acquire 56.34% stake in PacRay International Holdings Limited (SEHK:1010) from Vision2000 Venture Ltd. and other shareholders for approximately HKD 280 million.

New 90-day high: HK$0.90

New 90-day low: HK$0.70

First half earnings released

PacRay International Holdings Limited (SEHK:1010) completed the acquisition of 20.2% stake in Meridian Aviation Holdings Limited from Duan Hong Tao and Wang Yi.

First half earnings released

Pacray International Holdings Limited Announces Resignation of Xu Beinan as Chief Executive Officer

PacRay International Holdings Limited to Report First Half, 2020 Results on Aug 28, 2020

New 90-day high - HK$1.79

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견